Analyst Graham Parry from Bank of America Securities maintained a Hold rating on Novartis AG (NOVN – Research Report) and decreased the price ...

Berenberg Bank analyst Luisa Hector maintained a Hold rating on Novartis AG (NOVN – Research Report) today and set a price target of ...

The Federal Circuit reversed a Delaware district court’s 2023 ruling axing a Novartis Pharmaceuticals Corp. patent covering ...

Versant Capital Management Inc boosted its holdings in shares of Novartis AG (NYSE:NVS – Free Report) by 782.0% in the fourth quarter, according to the company in its most recent 13F filing with the ...

Novartis AG said a new experimental medicine improved motor function in children with a form of spinal muscular atrophy, the ...

The curtain is coming down on one of Europe’s longest-established biopharmas, with Novartis AG announcing it is to shut Morphosys AG’s facilities, following its 2024 acquisition of the one-time ...

Light Horse Therapeutics is off to the races, rounding up a $62 million series A and tacking on a Novartis partnership that ...

Swiss drugmaker Novartis said on Monday its gene therapy helped improve motor function in children with a rare muscle disorder that leaves patients too weak to walk, talk and swallow. Novartis ...

Investing in healthcare equities is typically seen as protective during recessionary times. This is because, even in hard financial times, consumers usually do not reduce their usage of ...

We recently compiled a list of the 12 Cheap Healthcare Stocks to Buy Heading into 2025. In this article, we are going to take ...

Ad hoc announcement pursuant to Art. 53 LR The Phase III STEER study met its primary endpoint showing an increase from baseline in HFMSE total score in patients with SMA treated with intrathecal ...